Astera Labs (NASDAQ:ALAB) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Astera Labs (NASDAQ:ALAB) released its quarterly earnings data on Tuesday. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07, FiscalAI reports. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs updated its Q2 2026 guidance to 0.680-0.700 EPS.

Here are the key takeaways from Astera Labs’ conference call:

• Astera Labs reported strong Q1 results with $308.4 million in revenue (up 14% sequential, 93% YoY), non‑GAAP EPS of $0.61, roughly $1.18 billion in cash, and Q2 guidance of $355–365 million revenue and $0.68–0.70 EPS.
• The expanded Scorpio switch family — including the new 320‑lane Scorpio X-Series with hardware‑accelerated Hypercast and in‑network compute — is shipping initial volumes and is expected to ramp to production in H2 2026, positioning Scorpio to become the company’s largest product line.
• PCIe Gen 6 adoption is accelerating (Gen6 products drove over one‑third of revenue), advancing Aries/Taurus adoption and supporting management’s claim of increasing silicon dollar content to over $1,000 per XPU in AI racks.
• Astera is advancing its optical roadmap after the XSCALE/aiXscale integration, targeting volume shipments for near‑package optics and pluggable connector solutions starting in 2027, but these initiatives remain multi‑year with supply and qualification risks.
• Custom solutions and memory initiatives are progressing — the Leo CXL controller is on track with Microsoft Azure M‑series and Astera won a KV‑cache offload design win (shipments expected in 2027), with additional hyperscaler engagements for NVLink Fusion and other custom programs.

Astera Labs Stock Up 7.2%

Shares of ALAB traded up $14.44 during mid-day trading on Tuesday, reaching $215.69. 7,992,940 shares of the company’s stock were exchanged, compared to its average volume of 5,897,388. The company has a 50-day simple moving average of $139.00 and a two-hundred day simple moving average of $153.00. The company has a market cap of $36.94 billion, a price-to-earnings ratio of 186.34, a PEG ratio of 3.96 and a beta of 3.35. Astera Labs has a 52-week low of $63.40 and a 52-week high of $262.90.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ALAB shares. Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. UBS Group assumed coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Citigroup began coverage on Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Finally, Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday. They issued a “neutral” rating and a $153.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $199.20.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 10,188 shares of the stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the transaction, the chief executive officer directly owned 4,069,134 shares in the company, valued at approximately $713,929,560.30. This represents a 0.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,064,888 shares of company stock worth $150,764,723 in the last ninety days. 12.50% of the stock is currently owned by insiders.

Institutional Trading of Astera Labs

A number of hedge funds have recently made changes to their positions in the company. Amundi grew its stake in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. State Street Corp lifted its holdings in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Astera Labs by 162.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,164,414 shares of the company’s stock worth $193,713,000 after purchasing an additional 720,844 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Astera Labs during the third quarter worth approximately $131,539,000. Finally, Holocene Advisors LP acquired a new position in Astera Labs in the second quarter worth approximately $55,827,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 earnings and revenue beat consensus — EPS $0.61 vs. $0.54 est.; revenue $308.4M, up 93% year-over-year and above expectations, showing rapid top-line expansion. Astera Labs Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised Q2 (FY26 Q2) guidance sharply — EPS guide of $0.680–0.700 vs. street ~$0.50 and revenue guidance ~$355–365M vs. ~$310M consensus, implying continued acceleration into the quarter. Q1 Press Release / Guidance
• Positive Sentiment: Company points to AI spending as a key growth driver and raised investor expectations that demand from hyperscalers and AI customers is sustaining strong order flow. Astera Labs jumps as AI spending buoys Q1 results, guidance
• Positive Sentiment: Product traction: new Scorpio X‑Series 320‑lane smart fabric switch now shipping to leading hyperscalers, supporting the company’s positioning in rack‑scale AI connectivity. Scorpio X-Series Product Release
• Positive Sentiment: Third‑party sentiment and coverage supportive — analysts have an average “Moderate Buy” and prominent commentators (e.g., Jim Cramer) publicly bullish ahead of/around the report, reinforcing investor interest. Analyst Rating Jim Cramer Comment
• Neutral Sentiment: Sector tailwinds: broader chip/semiconductor stocks rallied recently, which likely amplified the stock’s move as investors rotated into AI- and infrastructure-exposed names. Chip Stocks Rally

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.